[Long-term results of multimodality therapy of small cell bronchial cancer including surgery].
The results of a prospective Phase II study of a multimodal treatment regimen including surgery of operable stages of small cell lung cancer are reported. Of 45 patients 24 received all parts of the projected treatment. The 5-year survival probability is 56% and 8 patients are still living after more than 60 months. Eleven patients with N2 lymph node metastases receiving the complete therapy have a projected 5-year survival of 60%.
Salzer
G M
GM
II. Univ. Klinik für Chirurgie, Innsbruck.
Präuer
H
H
Müller
L
L
Huber
H
H
Frommhold
H
H
D001317:Austria; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D011013:Pneumonectomy; D011446:Prospective Studies; D015996:Survival Rate
Langzeitergebnisse nach multimodaler Therapie des kleinzelligen Bronchialkarzinoms mit Einschluss der Chirurgie.